Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
osteoarthritis
Biotech
Galapagos cleans closet of another 4 programs in CAR-T pivot
The Belgian biotech has managed to find another four early-stage programs worthy of being culled in favor of its CAR-T strategy.
James Waldron
Aug 5, 2022 10:03am
Déjà vu: FDA rejects Ampio’s COVID-ravaged osteoarthritis trial
Apr 21, 2022 6:09am
Fierce Biotech’s top 10 data readouts in 2022
Dec 20, 2021 3:00am
Lilly, Pfizer stop study of arthritis drug after FDA rejection
Oct 26, 2021 9:20am
AstraZeneca, others support newly private Cellular with $120M
Sep 30, 2021 10:54am
Haisco to pay Biosplice $140M for osteoarthritis drug in China
Sep 15, 2021 10:33am
